Your browser doesn't support javascript.
loading
Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis.
Cai, Lin; Zhang, Jian-Zhong; Zheng, Min; Zhang, Shi-Fa; Patekar, Manmath.
Affiliation
  • Cai L; Department of Dermatology, Peking University People's Hospital, Beijing 100044, China.
  • Zhang JZ; Department of Dermatology, Peking University People's Hospital, Beijing 100044, China.
  • Zheng M; Department of Dermatology, Second Affiliated Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310.
  • Zhang SF; Department of Dermatology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110016, China.
  • Patekar M; Novartis Pharma AG, Basel, Switzerland.
Chin Med J (Engl) ; 134(21): 2629-2631, 2021 Sep 15.
Article in En | MEDLINE | ID: mdl-34748527
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Arthritis, Psoriatic Limits: Humans Country/Region as subject: Asia Language: En Journal: Chin Med J (Engl) Year: 2021 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Arthritis, Psoriatic Limits: Humans Country/Region as subject: Asia Language: En Journal: Chin Med J (Engl) Year: 2021 Document type: Article Affiliation country: China